Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine

The combination of cisplatin and gemcitabine is still one of the most frequently used first-line chemotherapy scheme in patients with advanced non-small cell lung cancer (NSCLC), in which tyrosine kinase inhibitors (TKIs) cannot be administered. Unfortunately, more than half of the patients have no...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pathol Oncol Res
Auteurs principaux: Mlak, Radosław, Krawczyk, Paweł, Homa-Mlak, Iwona, Powrózek, Tomasz, Ciesielka, Marzanna, Kozioł, Piotr, Milanowski, Janusz, Małecka-Massalska, Teresa
Format: Artigo
Langue:Inglês
Publié: Springer Netherlands 2018
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6614130/
https://ncbi.nlm.nih.gov/pubmed/30066234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-018-0459-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires